Besides its COMET-funded projects, CBmed is offering customer-tailored contract research within CBsolutions. In cooperation with our partners we are providing a wide variety of services. Starting with the definition of specific research questions, our team can set up clinical trials from study design to execution until completion.

Our Public-Privat-Partnership Model for tailored biomarker solutions.

Linking our cutting-edge Core Technologies together with specialized services of our widespread scientific partner network, we are capable of handling projects with a very high degree of complexity. Standardized workflows guarantee reproducible results. Highest quality standards from sample acquisition until delivery of lab results are utmost importance for us. Beyond on demand-services we additionally provide joint approaches to 3rd party funding within Europe and abroad, together with experienced consortium partners from academia and industry.

Retrospective & Prospective Clinical cohorts

Biobanks

Vienna General Hospital

In the top 10 largest hospitals in EU
> 450 specialized outpatient units
~ 2,000 beds
~ 114,000 inpatients/year
~ 1,773,000 outpatients/year

Styria region including Graz

Network of 23 hospital sites in Styria including
University Clinic Graz
~ 5,800 beds
~ 250,000 inpatients/year
~ 950,000 outpatients/year

BBMRI-ERIC and BioBank Graz

European Biobank Consortium with HQ in Graz
515 biobanks with
> 60 million biospecimens
> 7 million directly in Graz


Selected Projects

  • Flow cytometry analysis of the InterFAST cohort
  • Method establishment and mutation analysis in colon carcinoma
  • Biomarker research based on a retrospective clinical study with candidate expression confirmation in ovarian carcinoma using digital pathology
  • Biomarker research based on a prospective clinical study with candidate expression confirmation and analysis in clear cell renal cell carcinoma using digital pathology
  • Study design for RNA sequencing for head and neck cancer
  • FACS analysis for the impact of hypoglycaemia in patients with DIAbetes mellitus type 2 on PLATElet activation (DIAPLATE) study
  • Treg subtype FACS analysis in the peripheral blood of kidney transplant recipients
  • Application of an MS-platform in pulmonary hypertension disease

 

Lucas Pflanzl-Knizacek
ルーカス   フランツル-ニーザチェック
프란츨크니자첵 루카스

Director of Business Development
事業開発部長
사업개발팀 이사

lucas.pflanzl@cbmed.at
+43 316 385 78043

Julia Schmidt
ジュリア シュミット
슈미츠 율리아

Business Development Manager
事業開発    マネージャー
사업개발팀 책임

julia.schmidt@cbmed.at

Nagaharu Yamatani
山谷 長治

Business Development Consultant Japan
コンサルタント

nagaharu.yamatani@cbmed.at
+81 90 5509 1188

Ji Young Park
박지영

Business Development Assistant
사업개발팀 선임

jiyoung.park@cbmed.at

The COMET Center CBmed is funded within COMET – Competence Centers for Excellent Technologies by the Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK), the Federal Ministry for Digital and Economic Affairs (BMDW), Land Steiermark (Styrian Business Promotion Agency – SFG) and Land Wien (Vienna Business Agency – WAW). The COMET program is executed by the Austrian Research Promotion Agency (FFG).

CBmed GmbH Center for Biomarker Research in Medicine
Stiftingtalstrasse 5   8010 Graz   Austria   office@cbmed.at   +43 316 385 28801

PRESS CORNER     CONTACT     IMPRINT     PRIVACY

Font Resize
Contrast